Thomas Joseph Russo - 20 Dec 2023 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Financial Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
20 Dec 2023
Net transactions value
-$234,720
Form type
4
Filing time
22 Dec 2023, 18:26:26 UTC
Previous filing
01 Aug 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale $166,210 -10,753 -20% $15.46 42,467 20 Dec 2023 Direct F1, F2
transaction ICVX Common Stock Sale $68,510 -4,430 -10% $15.46 38,037 20 Dec 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover withholding taxes upon accelerated vesting of restricted stock unit awards pursuant to a Rule10b5-1 instruction letter dated December 6, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.41 to $15.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Reflects shares sold to cover taxes arising upon accelerated vesting of restricted stock unit awards.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $15.48. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.